Braden Scale Calculator
Calculate the Braden Scale score for pressure-injury risk using sensory, moisture, activity, mobility, nutrition, and friction or shear subscales.
EASI Score Calculator
Calculate the Eczema Area and Severity Index (EASI) for atopic dermatitis using the standard 4-region weighted scoring method.
⚠️ Medical Disclaimer: EASI scoring requires trained clinical assessment. This tool assists calculation but does not replace dermatologic evaluation.
Head & Neck (×0.1)
Trunk (×0.3)
Upper Limbs (×0.2)
Lower Limbs (×0.4)
EASI Score10.3 / 72
Severity
10.3
Moderate
Head & Neck
1.0
Trunk
4.5
Upper Limbs
1.6
Lower Limbs
3.2
EASI Score⧉
10.3
Moderate: Moderate eczema — mid-potency topicals, consider calcineurin inhibitors
Head & Neck⧉
1.0
×0.1 multiplier
Trunk⧉
4.5
×0.3 multiplier
Upper Limbs⧉
1.6
×0.2 multiplier
Lower Limbs⧉
3.2
×0.4 multiplier
Half of Current Score⧉
5.2
Not an EASI-50 response target unless you compare against a documented baseline score
| Severity | EASI Range | Treatment Approach |
|---|---|---|
| Clear | 0 | Maintenance emollients |
| Mild | 0.1-7.0 | Topical emollients, low-potency corticosteroids |
| Moderate | 7.1-21.0 | Mid-potency topicals, calcineurin inhibitors, phototherapy |
| Severe | 21.1-50.0 | High-potency topicals, systemic immunosuppression |
| Very Severe | 50.1-72.0 | Biologic therapy (dupilumab), systemic agents |
| Body Region | Weight | % of Total BSA |
|---|---|---|
| Head & Neck | 0.1 (10%) | ~10% of BSA |
| Trunk | 0.3 (30%) | ~30% of BSA |
| Upper Limbs | 0.2 (20%) | ~20% of BSA |
| Lower Limbs | 0.4 (40%) | ~40% of BSA |
Planning notes, formulas, and examples
About the EASI Score Calculator
The Eczema Area and Severity Index (EASI) is a validated outcome measure for assessing atopic dermatitis severity. It evaluates four clinical signs — erythema, edema or papulation, excoriation, and lichenification — across four body regions weighted by body surface area proportion.
EASI scores range from 0 to 72, with commonly used severity bands from clear to very severe. Response endpoints such as EASI-50 or EASI-75 require comparison with a documented baseline score rather than simple interpretation of a single visit in isolation.
This calculator is designed for structured EASI scoring in clinical practice, treatment monitoring, and research documentation. The regional breakdown helps show which body areas are driving the current score.
When This Page Helps
Atopic dermatitis often changes gradually over time, so structured measurement is more useful than a vague description like “better” or “worse.” EASI gives a reproducible way to document current severity and compare visits more consistently.
It is especially useful when treatment decisions, follow-up notes, or research-style documentation need an objective severity framework.
How to Use the Inputs
- Examine each body region: head and neck, trunk, upper limbs, and lower limbs.
- Estimate the area involvement score for each region.
- Grade erythema, edema or papulation, excoriation, and lichenification in each region.
- Review the total EASI score and current severity classification.
- If you are tracking response, compare the score with a recorded baseline rather than the current score alone.
Formula used
EASI = 0.1 × (Head signs sum × area) + 0.3 × (Trunk signs sum × area) + 0.2 × (Upper limb signs sum × area) + 0.4 × (Lower limb signs sum × area)
Signs sum = Erythema + Edema/Papulation + Excoriation + Lichenification
Each sign is scored 0-3
Area is scored 0-6
Range: 0-72Example Calculation
Result: EASI 12.0 — Moderate
With moderate area involvement and mild-to-moderate sign intensity across multiple regions, the weighted total is 12.0, which falls in the moderate range. That score describes current severity; treatment response still requires comparison with a baseline visit.
Tips & Best Practices
- Score the representative average severity within a region, not just the worst single lesion.
- Record a baseline score before major treatment changes whenever possible.
- Use the same scoring approach at follow-up visits to make comparisons more meaningful.
- Keep in mind that regional weights matter; lower-limb involvement contributes more than head-and-neck involvement.
- Response endpoints like EASI-50 only make sense when baseline and follow-up scores are both documented.
- Photos can complement EASI documentation but do not replace a numeric score.
Current Severity Versus Response
EASI is excellent for describing how severe the dermatitis looks at a given visit. It is also useful for response tracking, but only when the current score is compared against a true baseline.
Why the Regional Weights Matter
Each body region contributes differently because the weighting is based on the approximate proportion of body surface area represented by that region. That is why identical sign intensity can affect the total score differently depending on location.
Practical Use
For routine care, the main value is consistency. If the same team uses the same approach over time, EASI becomes a strong way to show whether the patient is meaningfully improving, stable, or flaring.
Sources & Methodology
Last updated:
Methodology
This calculator applies the canonical EASI framework by scoring area involvement from 0 to 6 in each of the four body regions and the four clinical signs from 0 to 3 per region, then multiplying each regional subtotal by the standard body-region weight before summing the total 0-to-72 score. The goal is structured severity documentation for atopic dermatitis using the same framework commonly used in trials and dermatology follow-up.
The page treats EASI as a current-severity measure. Response endpoints such as EASI-50, EASI-75, and EASI-90 require comparison with a documented baseline score, so they should not be inferred from the current score alone without a baseline value.
Sources
- The Eczema Area and Severity Index (EASI): assessment of reliability in atopic dermatitis (PubMed / Experimental Dermatology)
- HOME for Eczema (HOME initiative) — Outcome-measure standardization background for EASI use in eczema studies.
Frequently Asked Questions
EASI-50 means the current EASI score is 50% lower than a documented baseline score. It is a response endpoint, not a number you can infer from a single visit by halving the current score. EASI-75 and EASI-90 work the same way.
That depends on the care setting. It is often repeated during treatment changes, clinical follow-up, or trial visits so the direction and magnitude of change can be documented consistently.
It is reasonably reliable when assessors are trained and use the score consistently, but any clinical scoring system is still improved by shared definitions and experience.
EASI focuses on physician-assessed signs and area. SCORAD includes more patient-symptom content such as itch and sleep loss, so the two tools answer related but not identical questions.
EASI can help describe disease burden and track response, but actual biologic decisions depend on Complete View: treatment history, symptom burden, body area involved, guideline criteria, and payer rules.
Yes, EASI is widely used in children as well as adults. The same basic scoring framework applies, although treatment decisions and interpretation still depend on age and clinical context.
More in this topic
Beighton Score Calculator
Calculate the Beighton Score for joint hypermobility assessment. Tests 9 points across 5 maneuvers to evaluate generalized joint laxity and EDS screening.
Aldrete Score Calculator
Calculate the Modified Aldrete Score for post-anesthesia recovery assessment. Determines PACU discharge readiness based on activity, breathing, circulation, consciousness, and SpO₂.